Leveraging collaboration in molecular pathology and skin cancer diagnostics

Leveraging collaboration in molecular pathology and skin cancer diagnostics

April 19, 2016

Trajan Scientific and Medical (Trajan) and the University of Melbourne have embarked on an investigative collaboration today in the fields of molecular pathology and skin cancer diagnostics.

Molecular testing techniques can be used to pursue more accurate cancer screening and disease diagnosis.

Trajan’s emerging tools in micro sampling, sample preparation and mass spectrometry interfaces have generated strong interest in these healthcare applications.

Eight Master of Biotechnology students from the University’s Faculty of Science will be undertaking two industry projects in these areas, with guidance from Trajan mentors Mr Paul Romeo, General Manager, Australia and New Zealand, and Mr Stephen Tomisich, Chief Executive Officer.

"We look forward to fresh insights from the teams, which will help shape Trajan’s roadmap for diagnostic technologies.” said Mr Tomisich.

Academic and industry partnerships are key to Trajan’s collaborative model for innovation, accelerating delivery of scientific and medical solutions to the market that will make a positive impact on human wellbeing.


Photo (L-R): The University of Melbourne student teams at Trajan Global Headquarters in Melbourne, Australia. Paul Romeo (General Manager, Australia and New Zealand, Trajan), Keerthi Kalyan Kothapally, Seumas Shu Men Teh, Angela Tomisich (General Manager, Microscopy Products, Trajan), Robert Lyon (Head of Corporate Development, Trajan), Elpis Barons (General Manager, Accelerator Group, Trajan), Fiona Simpson (Careers and Industry Consultant, The University of Melbourne), Dr Andrew Gooley (Chief Scientific Officer, Trajan), Benjamin Nicholas Le Couteur, Belinda Bich Thuy Thieu Quang, Yanling Wu, Kairui Li, Jie Dong, Jingran Zhang, Rhonda Gailey (Assistant Manager, Corporate Development, Trajan), Dr Matthew Digby (Subject Coordinator, The University of Melbourne), Stephen Tomisich (Chief Executive Officer, Trajan).

More information
Research
The University of Melbourne




Also in News

Trajan Scientific and Medical announces partnership with award-winning PR consultancy LBPR to impact human wellbeing globally
Trajan Scientific and Medical announces partnership with award-winning PR consultancy LBPR to impact human wellbeing globally

July 25, 2017

Trajan Scientific and Medical has announced its investment in award-winning PR consultancy LBPR, based on an alignment of company values and a shared vision to impact human wellbeing around the world.

Read More

Trajan invests in Health Delivered - promoting pathways to better nutrition
Trajan invests in Health Delivered - promoting pathways to better nutrition

July 06, 2017

Trajan Scientific and Medical has invested in Health Delivered, an experienced team in dietetics, consumer health and digital platforms.

July 28th is the Australian showcase launch of the Health Delivered platform, and registered dietitians across Australia are invited to sign up to use the platform which will be rolled out for beta testing over the first two weeks of August.

Read More

On the cutting edge of 3D printing for portable devices
On the cutting edge of 3D printing for portable devices

June 20, 2017

ARC Future Fellow and Chief Investigator at the ARC Training Centre for Portable Analytical Separation Technologies (ASTech), Professor Michael Breadmore, has spent his research career working to simplify and speed up the analysis of chemical and biological samples, with an increasing emphasis on miniaturization.

Read More